The role of properdin and Factor H in disease

Claudio Cortes1, Caroline Desler2, Amanda Mazzoli2

  • 1Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, United States.

Advances in Immunology
|April 26, 2022
PubMed

Insights

The complement system is vital for immunity, regulated by proteins like Factor H and properdin. Dysregulation of these proteins, particularly Factor H, can cause severe diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Human Genetics

Background:

  • The complement system, comprising alternative, classical, and lectin pathways, is crucial for immunity and homeostasis.
  • Its functions include pathogen lysis, opsonization, inflammation, and clearance of cellular debris.
  • Proper regulation by complement regulatory proteins prevents host damage, as deficiencies can lead to various diseases.

Purpose of the Study:

  • To review the critical roles of Factor H and properdin in regulating the alternative complement pathway.
  • To explore the mechanisms of action for Factor H and properdin in host protection.
  • To discuss diseases linked to dysregulation, deficiencies, or mutations in Factor H and properdin.

Main Methods:

  • Review of scientific literature on complement regulatory proteins.
  • Analysis of in vitro, mouse, and human models investigating Factor H and properdin function.
  • Examination of clinical findings, management, and treatment strategies for associated diseases.

Main Results:

  • Factor H and properdin are key regulators of the alternative pathway, protecting against complement-mediated attack.
  • Deficiencies or mutations in Factor H and properdin lead to dysregulation of the alternative pathway.
  • Associated diseases include pro-thrombotic, renal, ocular, and autoimmune conditions.

Conclusions:

  • Factor H and properdin are essential for maintaining complement system balance and preventing disease.
  • Understanding their regulatory mechanisms is vital for diagnosing and treating associated human pathologies.
  • Further research using diverse models will elucidate the complex roles of these proteins in health and disease.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
948
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.8K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.5K
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.0K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K